Doctor profile · Federal record

Dr. Mussa Banisadre, MD

Hematology & Oncology Physician (CMS: Hematology) · Modesto, CA

  • NPI 1043264690
  • Accepts Medicare
  • MIPS 90.9 / 100 · 2023
  • 53 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1325 Melrose Ave, Suite A
Modesto, CA 953505508
(209) 524-7000
fax (209) 527-5601

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
April 14, 2008
Year of graduation
1973 — 53 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A38740

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1043264690. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,968
Distinct HCPCS
10
Medicare allowed
$148,083
HCPCS Description Services Patients Avg allowed
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,874 28 $0
J2469 Injection, palonosetron hcl, 25 mcg 1,020 20 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 542 236 $130
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 248 31 $30
96375 Injection of additional new drug or substance into vein 215 26 $16
96413 Administration of chemotherapy into vein, 1 hour or less 198 30 $139
96372 Injection of drug or substance under skin or into muscle 197 28 $15
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 110 14 $21
J1200 Injection, diphenhydramine hcl, up to 50 mg 100 22 $1
96415 Administration of chemotherapy into vein, each additional hour 91 18 $30

In context: peer comparison

Among 5 peers in this city , average services per provider: 429. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,659
Transactions
71
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 16 $589.52
Incyte Corporation 7 $320.59
ABBVIE INC. 7 $221.55
AstraZeneca Pharmaceuticals LP 7 $164.77
PFIZER INC. 6 $104.53
Merck Sharp & Dohme LLC 4 $99.97
Janssen Biotech, Inc. 3 $91.01
Celgene Corporation 4 $88.55
Astellas Pharma US Inc 3 $78.79
Daiichi Sankyo Inc. 3 $67.43
Genentech USA, Inc. 2 $64.52
E.R. Squibb & Sons, L.L.C. 3 $62.56
Stemline Therapeutics Inc. 2 $60.37
Ipsen Biopharmaceuticals, Inc 2 $56.45
Regeneron Healthcare Solutions, Inc. 2 $53.75

By nature of payment

Food and Beverage
$2,170
Long term medical supply or device loan
$299
Education
$189

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,063
Patients
300
Total drug cost
$626,234
Drug Type Claims Patients Total cost
Letrozole Generic 255 72 $11,075
Anastrozole Generic 128 32 $4,153
Tamoxifen Citrate Generic 118 31 $7,521
Hydroxyurea Generic 81 24 $3,424
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 77 20 $1,811
Ondansetron Hcl Generic 72 45 $1,683
Prednisone Generic 72 27 $664
Dexamethasone Generic 60 24 $1,077
Imatinib Mesylate Generic 39 0 $12,819
Furosemide Generic 34 12 $141

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mussa Banisadre's medical specialty?
Dr. Mussa Banisadre practices Hematology & Oncology Physician in Modesto, CA.
Where does Dr. Mussa Banisadre practice?
Dr. Mussa Banisadre practices at 1325 Melrose Ave, Modesto, CA 953505508. Office phone: 2095247000.
What is Dr. Mussa Banisadre's NPI?
Dr. Mussa Banisadre's National Provider Identifier (NPI) is 1043264690, issued by NPPES.
Does Dr. Mussa Banisadre accept Medicare assignment?
Yes. Dr. Mussa Banisadre accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mussa Banisadre commonly perform?
Top Medicare-reported procedures in 2023: Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Injection, palonosetron hcl, 25 mcg (HCPCS J2469); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.